Uptrend Under Pressure 100
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 100/100 · 7 distribution days (SPY) Oct 26 Full briefing →
View
Simple research view

RVTY · Revvity, Inc.

$160.39 +1.02% Oct 26 close
Detected setup Trend Only · Setup Score 98/100

Stand aside — setup invalidated

Setup score 98, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about RVTY

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$RVTY

Revvity, Inc.

Revvity, Inc. is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $18B.

Health Technology Medical Specialties stock Stage 2 · Advancing Base 1
$160.39 latest close
Market Structure
Trend structure: range
Latest event: bos (bullish)
Support 106.21–106.54 · 4 touches · moderate
Support 98.69–99.18 · 3 touches · moderate
Support 89.65–89.75 · 3 touches · moderate
Support 83.48–83.68 · 3 touches · moderate
Support 107.48–108.02 · 3 touches · moderate
Momentum Turn Watch
Bollinger Squeeze Bollinger band width (7.3%) is in the bottom quartile of its last 120 sessions — Legend's width-percentile squeeze (not a TTM/Keltner squeeze), so volatility is compressed and a sharper move often follows.
Early technical context only. Wait for price, volume, and the canonical setup trigger to confirm; this signal does not change readiness or the setup score.
Verdict · setup score 98/100 · data Oct 26 close · latest session

Stand aside — setup invalidated

Setup score 98, but distribution days reach 5 or more — stand aside until the condition resets.

Recent price action · daily
$125$150AugSepOct$160

What would change this verdict

What needs to turn for this to become buyable — the top failing checks across the legend council:

  • Minervini 2. Quarterly EPS growth ≥ 25% — -37.6% QoQ
  • Minervini 2. ROE ≥ 17% — ROE 3.3%
  • O'Neil C: Quarterly EPS acceleration ≥ 25% — -37.6% QoQ
  • O'Neil A: Annual earnings & revenue quality — Rev +3.7% | ROE 3.3%
  • Weinstein Volume expansion above average — Volume ratio 0.57x
  • Weinstein Weekly price coiling (Stage 2 consolidation) — Tightening weekly range confirms base
Minority view — the council disagrees here
  • Minervini: watch Trend-template read: 7/10 pass; wait for the soft misses to improve.
  • O'Neil: avoid CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
  • Weinstein: watch Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.
73 Strong
Legend Score · rates the stock Strong (73/100) — held back by eps growth

Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.

  • Relative Strength (25%) 96
  • Trend Template (25%) 100
  • Institutional Footprint (20%) 64
  • EPS Growth (15%) 30
  • Quality (SMR-like) (15%) 44

RS rank 95: top 5% of all stocks — true leadership. Trend template 8/8: price above rising 50/150/200-day lines — textbook uptrend structure. Institutional score 64: mild accumulation. EPS -0% last quarter — no earnings momentum. Quality 44: weak fundamentals (sales growth 30, return on equity 40, leverage 100). Updated 2026-10-27.

Earnings

Post-earnings setup

Next earnings Monday, October 26, 2026 Before market open Exact clock time not supplied by source

Deterministic evidence

RVTY+1.02%
Sector proxy · XLV+0.00%
Broad market · SPY+0.71%
Same completed session window ending 2026-10-26. RVTY was +1.02 points vs XLV. +0.31 points vs SPY.
CatalystUnavailable Stock reactionPositive Sector reactionWeak Opening surgeNo surge Event riskEarnings-driven

Session internals Mixed

Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.

Vs prior close+1.02% From the open+0.64% Range position50% GapNo gap
QQQ confirmationConfirming (+1.11%) SMH confirmationConfirming (+2.74%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $160.39 +1.0% Oct 26 close
52W High $166.25 3.5% below high
Wks Since High 0w 2w today
Base Depth 0.0% 11.8% today
RS Rank 90 percentile of scan
SMA 50 $140.95
Avg Vol 1,896,432
Rel Vol (Oct 26) 0.57× 1.29× on up days
More stats
52W Low $81.22
Tight Wks 0
Base B1
SMA 200 $110.78
RS Line vs High +0.0%
RS Line Slope +4.8% ▲
Group Rank #20/66
ADR% 3.8%
ATR(14) $5.59 (3.5%)
Vol Pace (live) N/A
A/D Days 18A / 8D
A/D Rating A+
VDU Bars 0/10 d
Power Trend 30d
Earnings in 6d
Position in 52-week range 93rdpercentile of the 52-week range
$81.22low
$166.25high

RVTY Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for RVTY.

Create Free Account

Technical Analysis Report Card

$RVTY · $160.39 · as of 2026-10-26 · multi-factor read
91
/ 100
Technicals 91/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$140.95 ↑
100-day$125.15 ↑
200-day$110.78 ↑
Bullish (50 > 200)

RSI (14)

Reading67.6 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateWeakening
Histogram-0.328

Weakening — MACD slipped below its signal line. Histogram expanding.

Bollinger Bands (20,2)

%B / Width104% · 7.3%
Squeeze — volatility compressing

Riding the upper band — strong momentum, but stretched. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol1.29 · Neutral
Rel volume0.57×
Pocket pivots · 10d0
5d vs 50d vol79%
Heavy vol up / down1 / 0

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

  • 1 heavy-volume up day vs 0 down in the last 20 sessions.

Support & Resistance

R · $166.2552-week high
Price · $160.39now
S · $146.70swing level
S · $140.08swing level
S · $120.89swing level

Fibonacci · Uptrend swing

23.6%$148.92
38.2%$138.20
50.0%$129.54
61.8%$120.88
78.6%$108.54

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for RVTY — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishRS 95 (leader)
Want this read in a legend's voice? Ask a Legend about RVTY
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (98/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.

Council consensus: 7 of 9 legends are Watching — building, not yet a confirmed buy.
Minervini Watch C Trend-template read: 7/10 pass; wait for the soft misses to improve.

partialMonitor Trend Only for tighter volatility contraction before entry. SEPA Grade B (4/7).

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $160.39, MA150 $114.29, MA200 $110.78
1.2 150-day MA > 200-day MAMA150 $114.29 vs MA200 $110.78
Failing evidence
2. Quarterly EPS growth ≥ 25%-37.6% QoQ
2. ROE ≥ 17%ROE 3.3%
7/10 checks
O'Neil Avoid D CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
Passing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 95
N: Near 52-week high or RS line new high3.5% below high | RS line new high: True
Failing evidence
C: Quarterly EPS acceleration ≥ 25%-37.6% QoQ
A: Annual earnings & revenue qualityRev +3.7% | ROE 3.3%
3/8 checks
Weinstein Watch C Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

mediumClassic Stage 2 advancing phase — strong weekly trend confirms uptrend. This is Weinstein's sweet spot: buy and hold while price remains above the 30-week MA.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $160.39 vs MA200 $110.78
Failing evidence
Volume expansion above averageVolume ratio 0.57x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
5/7 checks
dennis Watch C Turtle read: no Donchian signal. The system stays flat until price takes out the 20-day high.
Passing evidence
No breakdown below the 20-day channel20-day low $146.70
Volatility-unit sizing (1N ≈ 1% of equity)1N = $5.47 (3.41% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
S1: 20-day Donchian breakoutNot confirmed
S2: 55-day Donchian breakoutNot confirmed
5/7 checks
zanger Avoid D Zanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.
Passing evidence
Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $184.45-$192.47; trail the rest
Trail on the 10/20-day MA10-day MA $155.46 · 20-day MA $154.35 — exit the remainder on a close below the trail
Failing evidence
Named Zanger pattern onlyTrend Only is not one of Zanger's six
Not extended (≤5% above the breakout point)Data unavailable
3/6 checks
zweig Watch D Zweig read: part of his screen passes but not all: EPS growth above the market (≥15% QoQ); Reasonable price for the growth (P/E ≤ 35); Insider buying — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
Price strength (RS ≥ 70)RS score 95 — Zweig buys strength, not bargains
Breadth momentum: 10-day A/D ratio10-day A/D 1.17 (1995 adv / 1699 dec) — participation expanding
Failing evidence
EPS growth above the market (≥15% QoQ)-37.6% QoQ — Zweig wants growth above the S&P average
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 77.5x — no PEG or forward P/E stored
3/8 checks
Livermore Watch B Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$160.39
Relative strengthRS 95
Failing evidence
Volume vs average0.57x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Darvas Watch B Box-theory read: constructive evidence is present, but volume vs average is unresolved.

mediumBuilding the top of the box (3.5% from 52W high) — watch for a box breakout with volume expansion.

Passing evidence
Price$160.39
Relative strengthRS 95
Failing evidence
Volume vs average0.57x
Box top broken on heavy volumeNot confirmed
4/6 checks
Wyckoff Watch B Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$160.39
Relative strengthRS 95
Failing evidence
Volume vs average0.57x
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
4/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH NH
NH148RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +4 A+
A: 16 D: 12 Net: +465 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 4/7 met
B 4/7 criteria
Separate score from the Minervini Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✗ EPS acceleration ≥25% QoQ -38%
✗ Revenue growth ≥20% YoY +4%
✓ Gross margin ≥30% 54%
✗ ROE ≥17% 3%
✓ RS rating ≥80 (leadership) 95
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -3.5%

Method Playbook

Trade it like Zweig EXACT LEVELS · PRO
Zweig D · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the stock's recent consolidation high — Zweig buys strength in screened growers, not breakdowns.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Buy only when the growth screen passes: EPS growth above the market, PEG ≤ 1.5 (reasonable for the growth), insider buying, and RS leadership.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Define the loss before entry — Zweig's risk rule. Sell when the growth story breaks: earnings decelerate or the valuation stretches past reason.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Hold winners as long as earnings keep growing and the price holds its trend; sell half on a climax run.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit when EPS growth falls below the market, the PEG stretches past reason, insiders stop buying — or the Super Model flips the market to defensive.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Forming Patterns (predictive — not confirmed)

Head & Shoulders bearish forming
75% built

Possible head & shoulders top — not confirmed. Watch for a daily close below ~153.92 (neckline) to confirm, with measured-move risk toward ~141.59. A push back above 158.00 weakens the pattern; reclaiming 166.25 invalidates it.

Confirms below 153.92
Invalidates at 166.25
Left Shoulder 149.52
Head 166.25
Right Shoulder 158.00
Neckline 153.92
Target 141.59

LS 149.52 / head 166.25 / RS 158.00, neckline ~153.92, vol_fading=yes

Predictive pattern recognition is educational — most forming structures never confirm. Wait for the confirmation level before treating this as a setup.

Pattern Analysis

98 setup score
RS Score 95
Trend template 8/8 ✓
Why This Setup? D+W Confluence
Trend Only · schematic

Gatekeeper 8/8 | Strong trend (8/8) | Top RS (95) | Volume drying up (bullish) | RS at new high | RS Blue Dot | Power Trend | Stage 2

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

2/7 universals met
  • Clear of earnings — not met in 6 days — event risk
  • Risk is defined — not met No stop — undefined risk
  • Asymmetric reward — partly met No target set
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 0.6× average — light
  • A relative-strength leader — met RS rank 90
  • In a confirmed uptrend — met Stage 2 · Trend template 8/8
Why these seven? → The Universal Edge

Minervini Trend Template

8/8 ✓

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $160.39 vs SMA150 $114.29 / SMA200 $110.78
SMA 150 above SMA 200 SMA150 $114.29 vs SMA200 $110.78
SMA 200 trending up Slope +5.52 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $140.95
Price above SMA 50 $160.39 vs SMA50 $140.95
30%+ above 52-week low +97.5% from $81.22
Within 25% of 52-week high -3.5% from $166.25
RS score above 70 RS 95

Fundamentals

52W Range
93%
Mkt Cap SEC
17.9B
EPS QoQ
-38%
Rev YoY
+4%
ROE
3%
Gross Margin
54%
D/E
0.44
EPS TTM
$2.07
P/E TTM
77.5x
Float
112M
Insider
No Buy

Company

Company profile
Revvity, Inc.
RVTY · NYSE · Health Technology · Medical Specialties

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
8/8
W. RS
100
W. Support
$81.22
W. Resist
$166.25
W. Patterns
Cup & Handle
Weekly Structure

Scan History

20× streak
Oct 23: 55 (Momentum Flag)Oct 23: 68 (Momentum Flag)Oct 26: 96 (Trend Only)Oct 27: 98 (Trend Only)98
Oct 27
Trend Only ✓ Gate
98
Oct 26
Trend Only ✓ Gate
96 0.0%
Oct 23
Momentum Flag ✓ Gate
68 +1.0%
Oct 23
Momentum Flag ✓ Gate
55 +1.0%

Latest News

Headlines for RVTY
Loading headlines…

Get the full picture on RVTY

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial